These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 25545358)
21. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation. Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680 [TBL] [Abstract][Full Text] [Related]
22. Generation of a monoclonal antibody to the carboxy-terminal domain of tau by immunization with the amino-terminal domain of the amyloid precursor protein. Philippe B; Brion JP; Coppens E; Octave JN J Neurosci Res; 1996 Dec; 46(6):709-19. PubMed ID: 8978505 [TBL] [Abstract][Full Text] [Related]
23. C-H ... π interplay between Ile308 and Tyr310 residues in the third repeat of microtubule binding domain is indispensable for self-assembly of three- and four-repeat tau. Sogawa K; Okuda R; In Y; Ishida T; Taniguchi T; Minoura K; Tomoo K J Biochem; 2012 Sep; 152(3):221-9. PubMed ID: 22659094 [TBL] [Abstract][Full Text] [Related]
24. Effect of Melatonin on Tau aggregation and Tau-mediated cell surface morphology. Das R; Balmik AA; Chinnathambi S Int J Biol Macromol; 2020 Jun; 152():30-39. PubMed ID: 32044365 [TBL] [Abstract][Full Text] [Related]
25. How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability? Xu L; Zheng J; Margittai M; Nussinov R; Ma B ACS Chem Neurosci; 2016 May; 7(5):565-75. PubMed ID: 26854860 [TBL] [Abstract][Full Text] [Related]
26. A 31-residue peptide induces aggregation of tau's microtubule-binding region in cells. Stöhr J; Wu H; Nick M; Wu Y; Bhate M; Condello C; Johnson N; Rodgers J; Lemmin T; Acharya S; Becker J; Robinson K; Kelly MJS; Gai F; Stubbs G; Prusiner SB; DeGrado WF Nat Chem; 2017 Sep; 9(9):874-881. PubMed ID: 28837163 [TBL] [Abstract][Full Text] [Related]
27. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Schneider A; Biernat J; von Bergen M; Mandelkow E; Mandelkow EM Biochemistry; 1999 Mar; 38(12):3549-58. PubMed ID: 10090741 [TBL] [Abstract][Full Text] [Related]
29. Evidence for an intermediate in tau filament formation. Chirita CN; Kuret J Biochemistry; 2004 Feb; 43(6):1704-14. PubMed ID: 14769048 [TBL] [Abstract][Full Text] [Related]
30. The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments. Jeganathan S; von Bergen M; Mandelkow EM; Mandelkow E Biochemistry; 2008 Oct; 47(40):10526-39. PubMed ID: 18783251 [TBL] [Abstract][Full Text] [Related]
31. Linkage-dependent contribution of repeat peptides to self-aggregation of three- or four-repeat microtubule-binding domains in tau protein. Okuyama K; Nishiura C; Mizushima F; Minoura K; Sumida M; Taniguchi T; Tomoo K; Ishida T FEBS J; 2008 Apr; 275(7):1529-1539. PubMed ID: 18312411 [TBL] [Abstract][Full Text] [Related]
32. MARKing tau for tangles and toxicity. Drewes G Trends Biochem Sci; 2004 Oct; 29(10):548-55. PubMed ID: 15450610 [TBL] [Abstract][Full Text] [Related]
33. Tau neurotoxicity and rescue in animal models of human Tauopathies. Krüger L; Mandelkow EM Curr Opin Neurobiol; 2016 Feb; 36():52-8. PubMed ID: 26431808 [TBL] [Abstract][Full Text] [Related]
34. Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation. Jeganathan S; Hascher A; Chinnathambi S; Biernat J; Mandelkow EM; Mandelkow E J Biol Chem; 2008 Nov; 283(46):32066-76. PubMed ID: 18725412 [TBL] [Abstract][Full Text] [Related]
35. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450 [TBL] [Abstract][Full Text] [Related]
36. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites. Hoffmann R; Lee VM; Leight S; Varga I; Otvos L Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960 [TBL] [Abstract][Full Text] [Related]
37. Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation. Sonawane SK; Uversky VN; Chinnathambi S Cell Commun Signal; 2021 Feb; 19(1):16. PubMed ID: 33579328 [TBL] [Abstract][Full Text] [Related]
38. Tau oligomers and aggregation in Alzheimer's disease. Meraz-Ríos MA; Lira-De León KI; Campos-Peña V; De Anda-Hernández MA; Mena-López R J Neurochem; 2010 Mar; 112(6):1353-67. PubMed ID: 19943854 [TBL] [Abstract][Full Text] [Related]
39. Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau. Courade JP; Angers R; Mairet-Coello G; Pacico N; Tyson K; Lightwood D; Munro R; McMillan D; Griffin R; Baker T; Starkie D; Nan R; Westwood M; Mushikiwabo ML; Jung S; Odede G; Sweeney B; Popplewell A; Burgess G; Downey P; Citron M Acta Neuropathol; 2018 Nov; 136(5):729-745. PubMed ID: 30238240 [TBL] [Abstract][Full Text] [Related]
40. A Single-Chain Variable Fragment Antibody Inhibits Aggregation of Phosphorylated Tau and Ameliorates Tau Toxicity in vitro and in vivo. Li S; Yi Y; Cui K; Zhang Y; Chen Y; Han D; Sun L; Zhang X; Chen F; Zhang Y; Yang Y J Alzheimers Dis; 2021; 79(4):1613-1629. PubMed ID: 33459708 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]